1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,435 | 0,477 | 13:58 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 27.12.24 | Cereno Scientific has enrolled 9 additional patients in its Expanded Access Program with CS1 providing more long-term safety and efficacy data in rare disease PAH | 2 | Cision News | ||
| CERENO SCIENTIFIC Aktie jetzt für 0€ handeln | |||||
| 20.12.24 | Cereno Scientific announces that the registration of warrants and convertibles to Fenja and Arena has been completed and that delivery of the warrants has been initiated | 1 | Cision News | ||
| 16.12.24 | New preclinical data for Cereno Scientific's novel IP Receptor Agonist CS585 presented at the ASH Annual Meeting and Exposition 2024 | 1 | Cision News | ||
| 13.12.24 | Cereno Scientific to present and engage in partnering and investor meetings at Biotech Showcase 2025 during J.P. Morgan Healthcare Week in San Francisco | 3 | Cision News | ||
| 06.12.24 | Cereno Scientific to present preclinical data for drug candidate CS585 at the ASH Annual Meeting and Exposition 2024 | 1 | Cision News | ||
| 29.11.24 | Cereno Scientific reports insider share purchases | 1 | Cision News | ||
| 28.11.24 | Edison Investment Research publishes an updated research note of Cereno Scientific and an executive CEO interview with Sten R. Sörensen | 3 | Cision News | ||
| 28.11.24 | Cereno Scientific - A productive period with plenty more to come | 228 | Edison Investment Research | Cereno Scientific has released its Q324 results, marking a productive and strategically significant period. Following the positive top-line data from the Phase IIa safety study of CS1 in pulmonary arterial... ► Artikel lesen | |
| 26.11.24 | Cereno Scientific releases BioStock article highlighting Q3 Report 2024 | 2 | Cision News | ||
| 26.11.24 | CERENO SCIENTIFIC: Impactful third quarter for Cereno | 1 | Cision News | ||
| 21.11.24 | New preclinical data for Cereno Scientific's novel IP Receptor Agonist CS585 presented at the AHA Scientific Sessions 2024 | 2 | Cision News | ||
| 21.11.24 | Cereno Scientific AB: Cereno Scientific publishes the interim report for Q3 2024 (July 1-September 30) | 110 | GlobeNewswire (Europe) | The Board and Chief Executive Officer of Cereno Scientific AB here present the interim report for Q3 2024 (July 1-September 30).
Summary of the interim report for Q3 2024 (July 1-September 30)
Cereno... ► Artikel lesen | |
| 14.11.24 | CERENO SCIENTIFIC: BioStock has published an interview with CEO Sten R. Sörensen on the minimum 250 MSEK loan financing | 3 | Cision News | ||
| 13.11.24 | Preclinical data for Cereno Scientific's novel IP Receptor Agonist CS585 presented at ESC Congress 2024, now published in European Heart Journal | 1 | Cision News | ||
| 12.11.24 | Cereno Scientific - New SEK250m financing secures runway into 2026 | 239 | Edison Investment Research | Cereno Scientific has announced a new financing arrangement of at least SEK250m, with net proceeds expected to extend the runway into 2026, past several key clinical milestones. Secured from Fenja Capital... ► Artikel lesen | |
| 11.11.24 | Cereno Scientific secures minimum 250 MSEK loan financing to reach set milestones into 2026 | 1 | Cision News | ||
| 06.11.24 | Cereno Scientific's CEO on novel therapies for rare diseases | 1 | Cision News | ||
| 31.10.24 | Cereno Scientific participates at DNB Nordic Healthcare Conference 2024 | 2 | Cision News | ||
| 30.10.24 | Cereno Scientific presents at BioStock Life Science Summit 2024 | 1 | Cision News | ||
| 25.10.24 | Edison Investment Research increases valuation of Cereno Scientific to 4.05 BSEK or SEK 14.3 SEK/share after IPF selected as initial target indication for CS014 | 2 | Cision News |
Seite:
1 2 3 Weiter >>
59 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TEMPUS AI | 47,590 | 0,00 % | Tempus AI: KI-App 'olivia' und Pelosis Investition treiben Aktienkurs | ||
| IMMUNOVANT | 23,590 | 0,00 % | Immunovant, Inc. (IMVT): The Biotech Stock with Biggest Upside Potential | ||
| SUMMIT THERAPEUTICS | 22,100 | 0,00 % | Why Summit Therapeutics Stock Is Jumping Today | ||
| APOGEE THERAPEUTICS | 39,460 | 0,00 % | Apogee Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of APG333, its Novel Half-Life Extended TSLP Antibody for the Treatment of Respiratory and Broader I&I Conditions | Interim safety and pharmacokinetic data from Phase 1 healthy volunteers trial anticipated in 2H 2025 APG777 + APG333 can potentially address key drivers of respiratory diseases more broadly versus... ► Artikel lesen | |
| VERA THERAPEUTICS | 33,700 | 0,00 % | Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | BRISBANE, Calif., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on January 8, 2025, the Compensation Committee granted inducement awards consisting... ► Artikel lesen | |
| RECURSION PHARMACEUTICALS | 6,880 | 0,00 % | Recursion Pharmaceuticals, Inc. (RXRX): Revolutionizing Drug Discovery with AI and Strategic Collaborations for Strong Growth | ||
| QIAGEN | 45,845 | +0,56 % | Qiagen schüttet clever aus | Bei Qiagen profitieren Anleger nicht nur von verbesserten fundamentalen Aussichten: Das Unternehmen schüttet erneut Kapital über einen Reverse Stock Split aus - insgesamt 300 Mio. US-Dollar. Die Venloer... ► Artikel lesen | |
| ADMA BIOLOGICS | 16,200 | 0,00 % | EWTX Yields Over 300% Returns, ADMA Records 200% Gains - Did You Strike While The Iron Is Hot? | WASHINGTON (dpa-AFX) - Biotech investing is a high-stakes game that may not suit the faint-hearted due to its inherent volatility. However, this sector can offer astronomical returns when investors... ► Artikel lesen | |
| HARMONY BIOSCIENCES | 40,420 | 0,00 % | Harmony Biosciences (NASDAQ:HRMY) Earns Buy Rating from HC Wainwright | ||
| QUANTUM-SI | 2,440 | 0,00 % | Quantum-Si Incorporated: Quantum-Si Showcases Advances in Multiomics at the Festival of Genomics UK | Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company, announces its participation in the upcoming Festival of Genomics UK, taking place on... ► Artikel lesen | |
| EVOTEC | 7,945 | +0,63 % | Evotec mit positiven News - doch reicht das? | Nachdem es lange ruhig war bei Evotec, hat heute eine Meldung über Fördermittel aus Südkorea wieder für Aufmerksamkeit bei dem Titel gesorgt. Die Aktie von Evotec zählt gegen Mittag zu den sieben stärksten... ► Artikel lesen | |
| JANUX THERAPEUTICS | 40,840 | 0,00 % | Pre-market Movers: Cheetah Net Supply Chain Service, NLS Pharmaceutics, PSQ Holdings, Janux Therapeutics, Coherus BioSciences | CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.45 A.M. ET).In the Green Cheetah Net Supply Chain Service Inc. (CTNT) is up... ► Artikel lesen | |
| BIONTECH | 111,30 | -1,15 % | BioNTech-Aktie: Wird 2025 ein gutes Jahr? | Im vergangenen Jahr hat die BioNTech-Aktie nicht gerade mit einer starken Performance geglänzt. Worauf müssen sich Anleger 2025 einstellen? Was spricht für steigende Kurse, was dagegen? Verhaltener... ► Artikel lesen | |
| AVIDITY BIOSCIENCES | 30,880 | 0,00 % | Royal Bank of Canada Reiterates Outperform Rating for Avidity Biosciences (NASDAQ:RNA) | ||
| KEROS THERAPEUTICS | 11,435 | 0,00 % | Keros spikes as Teva deal takes effect; Cantor downgrades on trial setback |
CERENO SCIENTIFIC AB gehört der Branche Biotechnologie an. Der aktuelle Kurs liegt bei 0,434 Euro und damit -0,23 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CERENO SCIENTIFIC AB finden Sie auf Wallstreet Online.
